Company Description

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors.

The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.

It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors.

The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

IceCure Medical Ltd

Country	Israel
Founded	2006
Industry	Medical Devices
Sector	Healthcare
Employees	77
CEO	Eyal Shamir

Contact Details

Address: 7 Ha’Eshel Street, PO Box 3163 Caesarea, 3079504 Israel
Phone	972 4 623 0333
Website	icecure-medical.com

Stock Details

Ticker Symbol	ICCM
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001584371
CUSIP Number	M53071136
ISIN Number	IL0011224156
SIC Code	3841

Key Executives

Name	Position
Eyal Shamir	Chief Executive Officer and Director
Ronen Tsimerman CPA	Chief Financial Officer and Chief Operating Officer
Tlalit Bussi Tel-Tzure	Vice President of Business Development and Global Marketing
Merav Nir Dotan	Vice President of Human Resources
Galit Malik	Vice President of Operations and Service

Latest SEC Filings

Date	Type	Title
Feb 4, 2025	6-K	Report of foreign issuer
Jan 27, 2025	6-K	Report of foreign issuer
Jan 13, 2025	424B5	Filing
Jan 13, 2025	6-K	Report of foreign issuer
Jan 13, 2025	6-K	Report of foreign issuer
Jan 6, 2025	6-K	Report of foreign issuer
Jan 3, 2025	6-K	Report of foreign issuer
Dec 30, 2024	6-K	Report of foreign issuer
Dec 5, 2024	6-K	Report of foreign issuer
Nov 26, 2024	6-K	Report of foreign issuer

View All SEC Filings